The chemical class referred to as SAV1 Activators encompasses a diverse range of compounds that indirectly influence the activity of Salvador homolog 1 (SAV1), a scaffold protein integral to the Hippo signaling pathway. This pathway is crucial in controlling organ size, tissue homeostasis, and cellular responses such as proliferation and apoptosis. The compounds in this class do not directly activate SAV1 but instead modulate various upstream components or related processes of the Hippo pathway, leading to an indirect effect on SAV1.
These chemicals include inhibitors of key kinases in the pathway, such as Mst1/2 and LATS, as well as inhibitors affecting related cellular processes like cell adhesion, cytoskeletal dynamics, and signal transduction. For instance, inhibitors targeting the YAP-TEAD interaction or GSK-3 can create a cellular environment that favors the activation or enhancement of the Hippo pathway, consequently affecting the role of SAV1. The significance of these chemicals lies in their ability to alter the complex network of signals and interactions within the Hippo pathway. By targeting specific kinases or influencing related cellular mechanisms such as cytoskeletal organization and cell adhesion, these activators can indirectly modulate the function of SAV1.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verteporfin | 129497-78-5 | sc-475698 sc-475698A | 10 mg 100 mg | $354.00 $2764.00 | 5 | |
A benzoporphyrin derivative that inhibits YAP-TEAD interaction, potentially enhancing the Hippo pathway activity and thereby indirectly activating SAV1. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A Src family kinase inhibitor, which could influence the Hippo pathway and indirectly affect SAV1 activity. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
Inhibits GSK-3, a kinase that can modulate the Hippo pathway, potentially influencing SAV1 activity. | ||||||
Concanavalin A | 11028-71-0 | sc-203007 sc-203007A sc-203007B | 50 mg 250 mg 1 g | $119.00 $364.00 $947.00 | 17 | |
A lectin that can modulate cell adhesion and signal transduction, potentially affecting SAV1 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, which can influence cytoskeletal organization and potentially affect SAV1 through the Hippo pathway. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
A Cdc42 inhibitor, potentially influencing SAV1 activity through modulation of the cytoskeleton and Hippo pathway signaling. | ||||||